Increased NF-Κb Signalling Up-Regulates BACE1 Expression and its Therapeutic Potential in Alzheimer's Disease
Open accessAbstract
Elevated levels of β-site APP cleaving enzyme 1 (BACE1) were found in the brain of some sporadic Alzheimer's disease (AD) patients; however, the underlying mechanism is unknown. BACE1 cleaves β-amyloid precursor protein (APP) to generate amyloid β protein (Aβ), a central component of neuritic plaques in AD brains. Nuclear factor-kappa B (NF-κB) signalling plays an important role in gene regulation and is implicated in inflammation, oxidative stress and apoptosis. In this report we found that both BACE1 and NF-κB p65 levels were significantly increased in the brains of AD patients. Two functional NF-κB-binding elements were identified in the human BACE1 promoter region. We found that NF-κB p65 expression resulted in increased BACE1 promoter activity and BACE1 transcription, while disruption of NF-κB p65 decreased BACE1 gene expression in p65 knockout (RelA-knockout) cells. In addition, NF-κB p65 expression leads to up-regulated β-secretase cleavage and Aβ production, while non-steroidal anti-inflammatory drugs (NSAIDs) inhibited BACE1 transcriptional activation induced by strong NF-κB activator tumour necrosis factor-alpha (TNF-α). Taken together, our results clearly demonstrate that NF-κB signalling facilitates BACE1 gene expression and APP processing, and increased BACE1 expression mediated by NF-κB signalling in the brain could be one of the novel molecular mechanisms underlying the development of AD in some sporadic cases. Furthermore, NSAIDs could block the inflammation-induced BACE1 transcription and Aβ production. Our study suggests that inhibition of NF-κB-mediated BACE1 expression may be a valuable drug target for AD therapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NF-κB has been proposed as a molecular factor underlying some sporadic forms of Alzheimer's disease.
“Moreover, it has also been proposed as a molecular factor underlying some sporadic forms of AD (Chen et al., 2012).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Chen et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882 · see citing works
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182 · see citing works
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745 · see citing works
Schreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816 · see citing works
Structure, Regulation and Function of NF-kappaB
Siebenlist, U. K., Franzoso, G., & Brown, K. D. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,086 · see citing works
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · see citing works
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · see citing works
Schreck, R., Albermann, K., & Baeuerle, P. A. (1992) · Free Radical Research Communications · doi:10.3109/10715769209079515 · Cited by 1,411 · see citing works
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · see citing works
Wang, W., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., & Nelson, P. T. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5065-07.2008 · Cited by 827 · see citing works
Barger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 625 · see citing works
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., & Kaltschmidt, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2642 · Cited by 611 · see citing works
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating <i>BACE1</i> gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605 · see citing works
Self-citationSastre, M., Dewachter, I., Rossner, S., Bogdanovic, N., Rosen, E., Borghgraef, P., Evert, B. O., Dumitrescu-Ozimek, L., Thal, D. R., Landreth, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503839103 · Cited by 373 · see citing works
Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4396-06.2007 · Cited by 365 · see citing works
Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337 · see citing works
Miyamoto, S., & Verma, I. M. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60257-2 · Cited by 278 · see citing works
Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1
Christensen, M. A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., & Song, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.865-874.2004 · Cited by 221 · see citing works
Self-citationOxidative stress potentiates BACE1 gene expression and A? generation
Tong, Y., Zhou, W., Fung, V., Christensen, M. A., Qing, H., Sun, X., & Song, W. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0255-3 · Cited by 218 · see citing works
Self-citationTerai, K., Matsuo, A., & McGeer, P. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00310-1 · Cited by 215 · see citing works
Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing
Wen, Y., Yu, W. H., Maloney, B., Bailey, J. A., Ma, J., Marié, I., Maurin, T., Wang, L., Figueroa, H. Y., Herman, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.024 · Cited by 201 · see citing works
Guo, Q., Robinson, N., & Mattson, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12341 · Cited by 196 · see citing works
Bourne, K. Z., Ferrari, D. C., Lange‐Dohna, C., Roßner, S., Wood, T. G., & Perez-Polo, J. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21252 · Cited by 188 · see citing works
Sun, X., He, G., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-5632com · Cited by 158 · see citing works
Self-citationDegradation of BACE by the ubiquitin‐proteasome pathway
Qing, H., Zhou, W., Christensen, M. A., Sun, X., Tong, Y., & Song, W. (2004) · The FASEB Journal · doi:10.1096/fj.04-1994fje · Cited by 149 · see citing works
Self-citationDistinct transcriptional regulation and function of the human BACE2 and BACE1 genes
Sun, X., Wang, Y., Qing, H., Christensen, M. A., Liu, Y., Zhou, W., Tong, Y., Xiao, C., Huang, Y., Zhang, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3426com · Cited by 132 · see citing works
Self-citationNFκB-dependent Control of BACE1 Promoter Transactivation by Aβ42
Buggia-Prévot, V., Sévalle, J., Roßner, S., & Checler, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706579200 · Cited by 125 · see citing works
Control of APP processing and Aβ generation level by BACE1 enzymatic activity and transcription
Li, Y., Zhou, W., Tong, Y., He, G., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-4986com · Cited by 125 · see citing works
Self-citationExpression of the Alzheimer protease BACE1 is suppressed via its 5'‐untranslated region
Lammich, S., Schöbel, S., Zimmer, A., Lichtenthaler, S. F., & Haass, C. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400166 · Cited by 118 · see citing works
Alteration of transcription factors NF-κB and STAT1 in Alzheimer's disease brains
Kitamura, Y., Shimohama, S., Ota, T., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00797-0 · Cited by 113 · see citing works
Ibuprofen Decreases Cytokine-Induced Amyloid Beta Production in Neuronal Cells
Blasko, I., Apochal, A., Boeck, G., Hartmann, T., Grubeck‐Loebenstein, B., & Ransmayr, G. N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0451 · Cited by 92 · see citing works
Rogers, G. W., Edelman, G. M., & Mauro, V. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308576101 · Cited by 91 · see citing works
Leaky Scanning and Reinitiation Regulate BACE1 Gene Expression
Zhou, W., & Song, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3353-3364.2006 · Cited by 84 · see citing works
Self-citationTranslational regulation of BACE-1 expression in neuronal and non-neuronal cells
Tonelli, D. D. P. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh348 · Cited by 81 · see citing works
The Role of Sp1 and NF-κB in Regulating CD40 Gene Expression
Tone, M., Tone, Y., Babik, J. M., Lin, C., & Waldmann, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109889200 · Cited by 65 · see citing works
Self-citationThe proteins BACE1 and BACE2 and β-secretase activity in normal and Alzheimer's disease brain
Stockley, J. H., & O’Neill, C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350574 · Cited by 65 · see citing works
Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome
Sun, X., Tong, Y., Qing, H., Chen, C.-H., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-5628com · Cited by 63 · see citing works
Self-citationSaillé, C., Marin, P., Martinou, J., Nicole, A., London, J., & Ceballos-Picot, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00089-5 · Cited by 43 · see citing works
Gapuzan, M.-E. R., Schmah, O., Pollock, A. D., Hoffmann, A., & Gilmore, T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208809 · Cited by 41 · see citing works
SP1 regulates a human SNAP‐25 gene expression
Cai, F., Chen, B., Zhou, W., Zis, O., Liu, S., Holt, R. A., Honer, W. G., & Song, W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05167.x · Cited by 24 · see citing works
Self-citationBcl-2 expression in thalamus, brainstem, cerebellum and visual cortex of adult primate
Vinet, J., Bernier, P. J., & Parent, A. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00004-4 · Cited by 17 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Buggia-Prevot V, Sevalle J, Rossner S, Checler F (2008). NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. Journal of Biological Chemistry 283, 10037-10047.
Cited by
Sorted by citations
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179 · see citing works
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066 · see citing works
Neuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726 · see citing works
Inflammation: The Common Pathway of Stress-Related Diseases
Liu, Y.-Z., Wang, Y.-X., & Jiang, C.-L. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00316 · Cited by 800 · see citing works
Glycogen synthase kinase-3 signaling in Alzheimer's disease
Lauretti, E., Dincer, O., & Praticò, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118664 · Cited by 624 · see citing works
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606 · see citing works
Self-citationInhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Ly, P. T. T., Wu, Y., Zou, H., Wang, R., Zhou, W., Kinoshita, A., Zhang, M., Yang, Y., Cai, F., Woodgett, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64516 · Cited by 442 · see citing works
Self-citationThe role of astrocytes in amyloid production and Alzheimer's disease
Frost, G. R., & Li, Y. (2017) · Open Biology · doi:10.1098/rsob.170228 · Cited by 435 · see citing works
The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
Sun, E., Motolani, A., Campos, L., & Lu, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168972 · Cited by 369 · see citing works
Montgomery, S. L., & Bowers, W. J. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9287-2 · Cited by 365 · see citing works
Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy
Wang, C., Fan, L., Khawaja, R. R., Liu, B., Zhan, L., Kodama, L., Chin, M., Li, Y., Le, D., Zhou, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29552-6 · Cited by 333 · see citing works
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Bongarzone, S., Savickas, V., Luzi, F., & Gee, A. D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00058 · Cited by 313 · see citing works
PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease
Du, F., Yu, Q., Yan, S., Hu, G., Lue, L., Walker, D., Wu, L., Yan, S. F., Tieu, K., & Yan, S. S. (2017) · Brain · doi:10.1093/brain/awx258 · Cited by 306 · see citing works
Singh, S., & Singh, T. G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200207120949 · Cited by 299 · see citing works
Obulesu, M., & Lakshmi, M. J. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1454-4 · Cited by 290 · see citing works
Devi, L., & Ohno, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.191 · Cited by 282 · see citing works
Oxidative stress and β-amyloid protein in Alzheimer’s disease
Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · see citing works
Neuroinflammation in Alzheimer&rsquo;s disease
Zhang, F., & Jiang, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75546 · Cited by 276 · see citing works
Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
Seo, E.-J., Fischer, N., & Efferth, T. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.030 · Cited by 265 · see citing works
Targeting neuroinflammation in Alzheimer’s disease
Bronzuoli, M. R., Iacomino, A., Steardo, L., & Scuderi, C. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s86958 · Cited by 255 · see citing works
Nrf2: a dark horse in Alzheimer's disease treatment
Osama, A., Zhang, J., Yao, J., Yao, X., & Fang, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101206 · Cited by 251 · see citing works
NF-κB as an Inducible Regulator of Inflammation in the Central Nervous System
Anilkumar, S., & Wright-Jin, E. C. (2024) · Cells · doi:10.3390/cells13060485 · Cited by 244 · see citing works
Piro, J. R., Benjamin, D. I., Duerr, J. M., Pi, Y., Gonzales, C., Wood, K. M., Schwartz, J. W., Nomura, D. K., & Samad, T. A. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.05.001 · Cited by 223 · see citing works
Zhu, Z., Yan, J., Jiang, W., Yao, X., Chen, J., Chen, L., Li, C., Hu, L., Jiang, H., & Shen, X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4790-12.2013 · Cited by 207 · see citing works
The duality of amyloid-β: its role in normal and Alzheimer’s disease states
Azargoonjahromi, A. (2024) · Molecular Brain · doi:10.1186/s13041-024-01118-1 · Cited by 173 · see citing works
Hazan, S. (2020) · Journal of International Medical Research · doi:10.1177/0300060520925930 · Cited by 200 · see citing works
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Novoa, C., Salazar, P., Cisternas, P., Gherardelli, C., Vera-Salazar, R., Zolezzi, J. M., & Inestrosa, N. C. (2022) · Biological Research · doi:10.1186/s40659-022-00404-3 · Cited by 206 · see citing works
Yang, W., Liu, Y., Xu, Q., Xian, Y., & Lin, Z. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4754195 · Cited by 179 · see citing works
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease
Jha, N. K., Jha, S. K., Kar, R., Nand, P., Swati, K., & Goswami, V. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14687 · Cited by 160 · see citing works
The circular RNA ci RS ‐7 promotes APP and BACE 1 degradation in an NF ‐κB‐dependent manner
Shi, Z., Chen, T., Yao, Q., Zheng, L., Zhang, Z., Wang, J., Hu, Z., Cui, H., Han, Y., Han, X., et al. (2017) · FEBS Journal · doi:10.1111/febs.14045 · Cited by 159 · see citing works
Glia Crosstalk in Neuroinflammatory Diseases
Bernaus, A., Blanco, S., & Sevilla, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00209 · Cited by 157 · see citing works
Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
Snow, W. M., & Albensi, B. C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00118 · Cited by 157 · see citing works
Neuronal autophagy and mitophagy in Parkinson's disease
Lizama, B. N., & Chu, C. T. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100972 · Cited by 149 · see citing works
Zhang, M., Cheng, Q., Zheng, Z., Qian, F., Wang, Y., Thu, P. M., Zhang, X., Zhou, Y., Tu, L., Liu, Q., et al. (2018) · Theranostics · doi:10.7150/thno.26164 · Cited by 148 · see citing works
Liu, Q., Chen, Y., Shen, C., Xiao, Y., Wang, Y., Liu, Z., & Liu, X. (2016) · The FASEB Journal · doi:10.1096/fj.201601071r · Cited by 146 · see citing works
Yeo, I. J., Lee, C., Han, S., Yun, J., & Hong, J. T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107394 · Cited by 135 · see citing works
Oligodendrocytes and Alzheimer's disease
Cai, Z., & Xiao, M. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1025778 · Cited by 133 · see citing works
Rahman, S. O., Panda, B. P., Parvez, S., Kaundal, M., Hussain, S., Akhtar, M., & Najmi, A. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.043 · Cited by 129 · see citing works
Jones, S. V., & Kounatidis, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01805 · Cited by 128 · see citing works
Upstream regulators and downstream effectors of NF-κB in Alzheimer’s disease
Shi, Z.-M., Han, Y.-W., Han, X.-H., Zhang, K., Chang, Y.-N., Hu, Z.-M., Qi, H.-X., Ting, C., Zhen, Z., & Hong, W. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.022 · Cited by 125 · see citing works
He, P., Yan, S., Zheng, J., Gao, Y., Zhang, S., Liu, Z., Liu, X., & Xiao, C. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03731 · Cited by 120 · see citing works
Chami, L., Buggia-Prévot, V., Duplan, E., Delprete, D., Chami, M., Peyron, J., & Checler, F. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.333054 · Cited by 120 · see citing works
Shi, J., Zhang, C., Sun, X., Cheng, X., Wang, J., Zhang, Y., Xu, J. L., & Zou, H. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12066 · Cited by 116 · see citing works
Sanders, O. D., & Rajagopal, L. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200191 · Cited by 115 · see citing works
Gu, X., Xu, L.-J., Liu, Z., Wei, B., Yang, Y., Xu, G., Yin, X., & Wang, W. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.052 · Cited by 113 · see citing works
Okorji, U. P., Velagapudi, R., El‐Bakoush, A., Fiebich, B. L., & Olajide, O. A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9543-1 · Cited by 112 · see citing works
De Simone, A., Tumiatti, V., Andrisano, V., & Milelli, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00931 · Cited by 110 · see citing works
Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
Yu, J. E., Yeo, I. J., Han, S.-B., Yun, J., Kim, B., Yong, Y. J., Lim, Y.-S., Kim, T. H., Son, D. J., & Hong, J. T. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01131-9 · Cited by 109 · see citing works
Verma, A., Shteinfer‐Kuzmine, A., Kamenetsky, N., Pittala, S., Paul, A., Crystal, E. N., Ouro, A., Caspi, V. C., Pandey, S. K., Monsonego, A., et al. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00329-7 · Cited by 106 · see citing works
BACE1: More than just a β‐secretase
Taylor, H. A., Przemyłska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 102 · see citing works
Iliyasu, M. O., Musa, S. A., Oladele, S. B., & Iliya, A. I. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1081938 · Cited by 101 · see citing works
Fu, X., Zhang, J., Guo, L., Xu, Y., Sun, L., Wang, S., Feng, Y., Gou, L., Zhang, L., & Liu, Y. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.09.005 · Cited by 99 · see citing works
Regulation of β‐site APP‐cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease
Sun, X., Bromley‐Brits, K., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07515.x · Cited by 97 · see citing works
Self-citationNaeem, A., Prakash, R., Kumari, N., Ali Khan, M., Quaiyoom Khan, A., Uddin, S., Verma, S., AB Robertson, A., Boltze, J., & Shadab Raza, S. (2024) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.11.031 · Cited by 96 · see citing works
Zheng, K.-M., Dai, X., Xiao, N., Wu, X., Wei, Z., Fang, W., Zhu, Y., Zhang, J., & Chen, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9802-9 · Cited by 96 · see citing works
Marginal vitamin A deficiency facilitates Alzheimer’s pathogenesis
Zeng, J., Chen, L., Wang, Z., Chen, Q., Fan, Z., Jiang, H., Wu, Y.-L., Ren, L., Chen, J., Li, T.-Y., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1669-y · Cited by 83 · see citing works
Self-citationRajasekar, N., Nath, C., Hanif, K., & Shukla, R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0169-8 · Cited by 94 · see citing works
Ng, R. C.-L., Jian, M., Ma, O. K.-F., Bunting, M., Kwan, J., Zhou, G.-J., Krishnamoorthi, S., Iyaswamy, A., Chan, P., Li, M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0701-0 · Cited by 94 · see citing works
Wang, P., Guan, P., Wang, T., Yu, X., Guo, J., & Wang, Z. (2014) · Aging Cell · doi:10.1111/acel.12209 · Cited by 93 · see citing works
RetractedYan, H., Shen, C., Yin, Q., Sun, M., Ma, Y., & Liu, X. (2016) · Neurochemical Research · doi:10.1007/s11064-015-1814-8 · Cited by 93 · see citing works
Control of BACE1 degradation and APP processing by ubiquitin carboxyl‐terminal hydrolase L1
Zhang, M., Deng, Y., Luo, Y., Zhang, S., Zou, H., Cai, F., Wada, K., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07644.x · Cited by 92 · see citing works
Self-citationCalcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures
Chakroborty, S., & Stutzmann, G. E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.012 · Cited by 91 · see citing works
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Olajide, O. A., & Sarker, S. D. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00751-1 · Cited by 91 · see citing works
He, X., Wang, X., Yang, L., Yang, Z., Yu, W., Wang, Y., Liu, R., Chen, M., & Gao, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.001 · Cited by 89 · see citing works
Hou, T., Yang, H., Wang, W., Wu, Q., Tian, Y., & Jia, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171110 · Cited by 84 · see citing works
Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders
García‐Domínguez, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060417 · Cited by 85 · see citing works
Bellucci, A., Bubacco, L., Longhena, F., Parrella, E., Faustini, G., Porrini, V., Bono, F., Missale, C., & Pizzi, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00068 · Cited by 82 · see citing works
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases
Xu, P., Li, D.-B., Tang, X., Bao, X., Huang, J., Tang, Y.-P., Yang, Y., Xu, H., & Fan, X.-T. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8461-3 · Cited by 84 · see citing works
Hu, Y., Li, H., Zhang, J., Zhang, X., Xia, X., Qiu, C., Liao, Y., Chen, H., Song, Z., & Zhou, W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00658 · Cited by 81 · see citing works
Self-citationTargeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
Deardorff, W. J., & Grossberg, G. T. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1200972 · Cited by 80 · see citing works
Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer’s Disease
Rigacci, S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_1 · Cited by 80 · see citing works
Wang, R., Chen, S., Liu, Y., Diao, S., Xue, Y.-Q., You, X., Park, E. A., & Liao, F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662908 · Cited by 79 · see citing works
BACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis
Wang, Z., Xu, Q., Cai, F., Liu, X., Wu, Y., & Song, W. (2019) · JCI Insight · doi:10.1172/jci.insight.123431 · Cited by 78 · see citing works
Self-citationD’Mello, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115911 · Cited by 77 · see citing works
Bee venom ameliorates lipopolysaccharide-induced memory loss by preventing NF-kappaB pathway
Gu, S. M., Park, M. H., Hwang, C. J., Song, H. S., Lee, U. S., Han, S., Oh, K. W., Ham, Y. W., Song, M. J., Son, D. J., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0344-2 · Cited by 76 · see citing works
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes
Du, Y., Zhao, Y., Li, C.-B., Zheng, Q.-Y., Tian, J., Li, Z.-Y., Huang, T. Y., Zhang, W., & Xu, H.-X. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171193 · Cited by 66 · see citing works
Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption
Zhang, R., Liu, Y., Chen, Y., Li, Q., Marshall, C., Wu, T., Hu, G., & Xiao, M. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13194 · Cited by 75 · see citing works
MafK positively regulates NF-κB activity by enhancing CBP-mediated p65 acetylation
Hwang, Y.-J., Lee, E., Song, J., Kim, H.-R., Jun, Y.-C., & Hwang, K. (2013) · Scientific Reports · doi:10.1038/srep03242 · Cited by 74 · see citing works
Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73 · see citing works
Ribarič, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063245 · Cited by 72 · see citing works
Kim, J. Y., Lee, H. J., Lee, S., Jung, Y. H., Yoo, D. Y., Hwang, I. K., Seong, J. K., Ryu, J. M., & Han, H. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04175-w · Cited by 72 · see citing works
Yun, J., Yeo, I. J., Hwang, C. J., Choi, D., Im, H.-S., Kim, J. Y., Choi, W. R., Jung, M. H., Han, S., & Hong, J. T. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.013 · Cited by 72 · see citing works
Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes
Huang, D., Yu, M., Yang, S., Lou, D., Zhou, W., Zheng, L., Wang, Z., Cai, F., Zhou, W., Li, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0703-3 · Cited by 70 · see citing works
Self-citationZheng, Y. M., Deng, Y., Gao, J.-M., Lv, C., Lang, L.-H., Shi, J., Yu, C., & Gong, Q. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0300-2 · Cited by 70 · see citing works
Self-citationLi, J., Sun, M., Cui, X., & Li, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710020 · Cited by 70 · see citing works
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives
Bivona, G., Iemmolo, M., Agnello, L., Sasso, B. L., Gambino, C. M., Giglio, R. V., Scazzone, C., Ghersi, G., & Ciaccio, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010884 · Cited by 71 · see citing works
Panmanee, J., Nopparat, C., Chavanich, N., Shukla, M., Mukda, S., Song, W., Vincent, B., & Govitrapong, P. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12260 · Cited by 68 · see citing works
Self-citationNetwork Medicine for Alzheimer’s Disease and Traditional Chinese Medicine
Jarrell, J. T., Gao, L., Cohen, D. S., & Huang, X. (2018) · Molecules · doi:10.3390/molecules23051143 · Cited by 67 · see citing works
Marwarha, G., Raza, S., Prasanthi, J. R. P., & Ghribi, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070773 · Cited by 67 · see citing works
RetractedTan, J.-L., Li, Q.-X., Ciccotosto, G. D., Crouch, P. J., Culvenor, J. G., White, A. R., & Evin, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061246 · Cited by 66 · see citing works
Chinchalongporn, V., Shukla, M., & Govitrapong, P. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12470 · Cited by 66 · see citing works
Galvão, F., Grokoski, K. C., da Silva, B. B., Lamers, M. L., & Siqueira, I. R. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.007 · Cited by 66 · see citing works
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 65 · see citing works
Choi, J. Y., Yeo, I. J., Kim, K. C., Choi, W. R., Jung, J., Han, S., & Hong, J. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1269-3 · Cited by 65 · see citing works
RetractedActivation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
Zhang, Y., Chen, H., Feng, Y., Liu, M., Lu, Z., Hu, B., Chen, L., Zhang, Y., Liu, J., Cai, F., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00869-3 · Cited by 64 · see citing works
Self-citation3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice
Lazić, D., Sagare, A. P., Nikolakopoulou, A. M., Griffin, J. H., Vassar, R. J., & Zloković, B. V. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181035 · Cited by 64 · see citing works
Hambali, A., Kumar, J., Hashim, N. F. M., Maniam, S., Mehat, M. Z., Cheema, M. S., Mustapha, M., Adenan, M. I., Stanslas, J., & Hamid, H. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.712317 · Cited by 62 · see citing works
Wang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 62 · see citing works
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Zhao, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03031-9 · Cited by 62 · see citing works
Zhang, Z.-X., Li, Y., & Zhao, R. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2093-8 · Cited by 60 · see citing works
- Authors
- Chen, C.-H., Zhou, W., Liu, S., Deng, Y., Cai, F., Tone, M., Tone, Y., Tong, Y., & Song, W.
- Affiliations
- University of British Columbia (CA)
- University of Pennsylvania (US)
- Corresponding author
- Song, Weihong
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-18
- Volume
- 15
- Issue
- 01
- Pages
- 77-90
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2158215064
- Cited by
- 433
- References
- 41
- Citations by year
- 2026: 33 · 2025: 55 · 2024: 51 · 2023: 39 · 2022: 40 · 2021: 26 · 2020: 47 · 2019: 25 · 2018: 25 · 2017: 18 · 2016: 20 · 2015: 17 · 2014: 12 · 2013: 11 · 2012: 6
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Michael Smith Health Research BC
- Canada Research Chairs
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, BACE1, NF-κB signaling, NF-κB p65, beta-secretase, amyloid-beta production, APP processing, transcriptional regulation, nonsteroidal anti-inflammatory drugs, TNF-α, inflammation, therapeutic target
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Anti-Inflammatory Agents, Non-Steroidal, Brain, Humans, Promoter Regions, Genetic, Transcription, Genetic, Tumor Necrosis Factor-alpha, Signal Transduction, Up-Regulation, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Transcription Factor RelA, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review